BRSH — Bruush Oral Care Income Statement
0.000.00%
Last trade - 00:00
- $0.99m
- $3.13m
- $2.63m
2020 January 31st | 2021 January 31st | 2022 October 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0.207 | 0.901 | 2.63 |
Cost of Revenue | |||
Gross Profit | 0.141 | 0.61 | 1.81 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 1.58 | 9.25 | 14.1 |
Operating Profit | -1.38 | -8.35 | -11.5 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -1.38 | -8.89 | -8.77 |
Net Income After Taxes | -1.38 | -8.89 | -8.77 |
Net Income Before Extraordinary Items | |||
Net Income | -1.38 | -8.89 | -8.77 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -1.38 | -8.89 | -8.77 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -4.23 | -27.3 | -26.9 |
Dividends per Share |